Myeloma minute:BT062
Publicado: Jue Ene 07, 2010 4:12 pm
ASH 2009: Asher Chanan-Khan
Phase I Study of BT062 Given as Repeated Single Dose Once Every 3 Weeks in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
Asher A. Chanan-Khan, MD
Roswell Park Cancer Institute
Buffalo, NY
http://myeloma.org/ArticlePage.action?t ... goryId=454
texto.
http://myeloma.org/ArticlePage.action?t ... 05&aTab=-1
abrazos
Phase I Study of BT062 Given as Repeated Single Dose Once Every 3 Weeks in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
Asher A. Chanan-Khan, MD
Roswell Park Cancer Institute
Buffalo, NY
http://myeloma.org/ArticlePage.action?t ... goryId=454
texto.
http://myeloma.org/ArticlePage.action?t ... 05&aTab=-1
abrazos